FORA
Forian Inc.
Medical - Healthcare Information Services
Market Cap$68M
5Y Perf.-78.5%
Build Your Comparison
Side-by-side financial analysisFORA
CSGP
Z
INFU
Try popular comparisons:
Stock Comparison
FORA vs CSGP vs Z vs INFU
Revenue, margins, valuation, and 5-year total return — side by side.
CSGP
CoStar Group, Inc.
Real Estate - Services
Market Cap$12.77B
5Y Perf.-57.9%
Z
Zillow Group, Inc. Class C
Internet Content & Information
Market Cap$7.72B
5Y Perf.-65.8%
INFU
InfuSystem Holdings, Inc.
Medical - Instruments & Supplies
Market Cap$190M
5Y Perf.-50.2%
FORA vs CSGP vs Z vs INFU — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot |  FORA |  CSGP |  Z |  INFU |
|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Real Estate - Services | Internet Content & Information | Medical - Instruments & Supplies |
| Market Cap | $68M | $12.77B | $7.72B | $190M |
| Revenue (TTM) | $30M | $3.41B | $2.69B | $142M |
| Net Income (TTM) | $-5M | $25M | $61M | $8M |
| Gross Margin | 46.8% | 77.4% | 73.3% | 56.7% |
| Operating Margin | -13.4% | -0.8% | 0.4% | 9.1% |
| Forward P/E | — | 22.1x | 14.1x | 22.2x |
| Total Debt | $12K | $1.14B | $536M | $3M |
| Cash & Equiv. | $13M | $1.73B | $773M | $3M |
FORA vs CSGP vs Z vs INFU — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
FORA
CSGP
Z
INFU
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Forian Inc. (FORA) | 100 | 21.5 | -78.5% |
| CoStar Group, Inc. (CSGP) | 100 | 42.1 | -57.9% |
| Zillow Group, Inc. … (Z) | 100 | 34.2 | -65.8% |
| InfuSystem Holdings… (INFU) | 100 | 49.8 | -50.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FORA vs CSGP vs Z vs INFU
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: INFU leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and recent price momentum and sentiment. Forian Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. Z also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇INFU emerged as the overall leader. Track its performance:
FORA
Forian Inc.
The Income Pick
FORA is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- beta 0.21
- Rev growth 50.1%, EPS growth 23.0%, 3Y rev CAGR 22.6%
- Lower volatility, beta 0.21, Low D/E 0.0%, current ratio 2.97x
- Beta 0.21, current ratio 2.97x
Best for: income & stability and growth exposure
CSGP
CoStar Group, Inc.
The REIT Holding
CSGP lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: real estate exposure
Z
Zillow Group, Inc. Class C
The Value Play
Z is the clearest fit if your priority is value.
- Lower P/E (14.1x vs 22.1x)
Best for: value
INFU
InfuSystem Holdings, Inc.
The Long-Run Compounder
INFU carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 240.1% 10Y total return vs CSGP's 43.4%
- 5.6% margin vs FORA's -17.0%
- +52.2% vs CSGP's -62.1%
- 7.9% ROA vs FORA's -11.8%, ROIC 12.5% vs -7.5%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth |  FORA | 50.1% revenue growth vs INFU's 6.4% |
| Value |  Z | Lower P/E (14.1x vs 22.1x) |
| Quality / Margins |  INFU | 5.6% margin vs FORA's -17.0% |
| Stability / Safety | FORA | Beta 0.21 vs INFU's 1.22, lower leverage |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | INFU | +52.2% vs CSGP's -62.1% |
| Efficiency (ROA) | INFU | 7.9% ROA vs FORA's -11.8%, ROIC 12.5% vs -7.5% |
FORA vs CSGP vs Z vs INFU — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2022
FY 2024
FY 2025
FY 2025
FORA vs CSGP vs Z vs INFU — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLINFULAGGINGZ
Who Leads Where
INFU leads in 4 of 6 categories
FORA leads 0 • CSGP leads 0 • Z leads 0 • 1 tied
Explore the data ↓ZZillow Group, Inc. Cl…
0leads
CSGPCoStar Group, Inc.
0leads
FORAForian Inc.
0leads
INFUInfuSystem Holdings, …
4leads
6 Total Categories
CATEGORYLEADERvs FORAvs CSGPMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
INFU3/6
Valuation MetricsMultiples, price ratios, and targets
INFU3/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
INFU6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
INFU4/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
INFU leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CSGP is the larger business by revenue, generating $3.4B annually — 113.5x FORA's $30M. INFU is the more profitable business, keeping 5.6% of every revenue dollar as net income compared to FORA's -17.0%. On growth, CSGP holds the edge at +22.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | FORAForian Inc. |  CSGPCoStar Group, Inc. | ZZillow Group, Inc… | INFUInfuSystem Holdin… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $30M | $3.4B | $2.7B | $142M |
| EBITDAEarnings before interest/tax | -$4M | $278M | $221M | $26M |
| Net IncomeAfter-tax profit | -$5M | $25M | $61M | $8M |
| Free Cash FlowCash after capex | $2M | $241M | $431M | $20M |
| Gross MarginGross profit ÷ Revenue | +46.8% | +77.4% | +73.3% | +56.7% |
| Operating MarginEBIT ÷ Revenue | -13.4% | -0.8% | +0.4% | +9.1% |
| Net MarginNet income ÷ Revenue | -17.0% | +0.7% | +2.3% | +5.6% |
| FCF MarginFCF ÷ Revenue | +7.8% | +7.1% | +16.0% | +14.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.9% | +22.5% | +18.4% | -3.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.0% | +127.7% | +5.1% | +5.9% |
INFU leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
INFU leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 30.4x trailing earnings, INFU trades at a 98% valuation discount to CSGP's 1814.5x P/E. On an enterprise value basis, INFU's 7.5x EV/EBITDA is more attractive than CSGP's 71.6x.
| Metric | FORAForian Inc. | CSGPCoStar Group, Inc. | ZZillow Group, Inc… | INFUInfuSystem Holdin… |
|---|---|---|---|---|
| Market CapShares × price | $68M | $12.8B | $7.7B | $190M |
| Enterprise ValueMkt cap + debt − cash | $55M | $12.2B | $7.5B | $190M |
| Trailing P/EPrice ÷ TTM EPS | -23.48x | 1814.46x | 354.81x | 30.39x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 22.11x | 14.10x | 22.16x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 71.63x | 28.65x | 7.55x |
| Price / SalesMarket cap ÷ Revenue | 2.24x | 3.93x | 2.99x | 1.33x |
| Price / BookPrice ÷ Book value/share | 2.27x | 1.52x | 1.67x | 3.47x |
| Price / FCFMarket cap ÷ FCF | 23.49x | 311.35x | 32.83x | 7.97x |
INFU leads this category, winning 3 of 6 comparable metrics.
Profitability & Efficiency
INFU leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
INFU delivers a 14.0% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-17 for FORA. FORA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CSGP's 0.14x. On the Piotroski fundamental quality scale (0–9), INFU scores 8/9 vs CSGP's 5/9, reflecting strong financial health.
| Metric | FORAForian Inc. | CSGPCoStar Group, Inc. | ZZillow Group, Inc… | INFUInfuSystem Holdin… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | -17.2% | +0.3% | +1.3% | +14.0% |
| ROA (TTM)Return on assets | -11.8% | +0.2% | +1.1% | +7.9% |
| ROICReturn on invested capital | -7.5% | -0.9% | -0.5% | +12.5% |
| ROCEReturn on capital employed | -8.2% | -0.8% | -0.6% | +14.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.00x | 0.14x | 0.11x | 0.06x |
| Net DebtTotal debt minus cash | -$13M | -$589M | -$237M | $241,000 |
| Cash & Equiv.Liquid assets | $13M | $1.7B | $773M | $3M |
| Total DebtShort + long-term debt | $12,137 | $1.1B | $536M | $3M |
| Interest CoverageEBIT ÷ Interest expense | -48.78x | 1.58x | 5.22x | 15.54x |
INFU leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
INFU leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in INFU five years ago would be worth $4,979 today (with dividends reinvested), compared to $1,735 for FORA. Over the past 12 months, INFU leads with a +52.2% total return vs CSGP's -62.1%. The 3-year compound annual growth rate (CAGR) favors FORA at -2.5% vs CSGP's -29.3% — a key indicator of consistent wealth creation.
| Metric | FORAForian Inc. | CSGPCoStar Group, Inc. | ZZillow Group, Inc… | INFUInfuSystem Holdin… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.4% | -54.1% | -51.3% | +12.3% |
| 1-Year ReturnPast 12 months | +2.4% | -62.1% | -52.5% | +52.2% |
| 3-Year ReturnCumulative with dividends | -7.3% | -64.7% | -32.9% | -7.6% |
| 5-Year ReturnCumulative with dividends | -82.7% | -65.7% | -72.3% | -50.2% |
| 10-Year ReturnCumulative with dividends | -90.5% | +43.4% | -7.6% | +240.1% |
| CAGR (3Y)Annualised 3-year return | -2.5% | -29.3% | -12.5% | -2.6% |
INFU leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
Evenly matched — FORA and INFU each lead in 1 of 2 comparable metrics.
Risk & Volatility
FORA is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than INFU's 1.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. INFU currently trades 85.3% from its 52-week high vs CSGP's 30.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | FORAForian Inc. | CSGPCoStar Group, Inc. | ZZillow Group, Inc… | INFUInfuSystem Holdin… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.45x | 1.15x | 1.22x |
| 52-Week HighHighest price in past year | $2.71 | $97.43 | $93.88 | $11.04 |
| 52-Week LowLowest price in past year | $1.64 | $29.53 | $31.48 | $5.38 |
| % of 52W HighCurrent price vs 52-week peak | +80.1% | +30.9% | +34.2% | +85.3% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 31.0 | 31.1 | 41.5 |
| Avg Volume (50D)Average daily shares traded | 40K | 7.0M | 4.0M | 172K |
Evenly matched — FORA and INFU each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: CSGP as "Buy", Z as "Hold", INFU as "Buy". Consensus price targets imply 111.0% upside for Z (target: $68) vs 59.2% for INFU (target: $15).
| Metric | FORAForian Inc. | CSGPCoStar Group, Inc. | ZZillow Group, Inc… | INFUInfuSystem Holdin… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $61.18 | $67.75 | $15.00 |
| # AnalystsCovering analysts | — | 25 | 46 | 3 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +4.5% | +8.7% | +5.8% |
Insufficient data to determine a leader in this category.
Key Takeaway
INFU leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.
Best OverallInfuSystem Holdings, Inc. (INFU)Leads 4 of 6 categories
Loading custom metrics...
FORA vs CSGP vs Z vs INFU: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FORA or CSGP or Z or INFU a better buy right now?
For growth investors, Forian Inc.
(FORA) is the stronger pick with 50. 1% revenue growth year-over-year, versus 6. 4% for InfuSystem Holdings, Inc. (INFU). InfuSystem Holdings, Inc. (INFU) offers the better valuation at 30. 4x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate CoStar Group, Inc. (CSGP) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FORA or CSGP or Z or INFU?
On trailing P/E, InfuSystem Holdings, Inc.
(INFU) is the cheapest at 30. 4x versus CoStar Group, Inc. at 1814. 5x. On forward P/E, Zillow Group, Inc. Class C is actually cheaper at 14. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — FORA or CSGP or Z or INFU?
Over the past 5 years, InfuSystem Holdings, Inc.
(INFU) delivered a total return of -50. 2%, compared to -82. 7% for Forian Inc. (FORA). Over 10 years, the gap is even starker: INFU returned +240. 1% versus FORA's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FORA or CSGP or Z or INFU?
By beta (market sensitivity over 5 years), Forian Inc.
(FORA) is the lower-risk stock at 0. 21β versus InfuSystem Holdings, Inc. 's 1. 22β — meaning INFU is approximately 480% more volatile than FORA relative to the S&P 500. On balance sheet safety, Forian Inc. (FORA) carries a lower debt/equity ratio of 0% versus 14% for CoStar Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FORA or CSGP or Z or INFU?
By revenue growth (latest reported year), Forian Inc.
(FORA) is pulling ahead at 50. 1% versus 6. 4% for InfuSystem Holdings, Inc. (INFU). On earnings-per-share growth, the picture is similar: InfuSystem Holdings, Inc. grew EPS 181. 8% year-over-year, compared to -95. 1% for CoStar Group, Inc.. Over a 3-year CAGR, FORA leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FORA or CSGP or Z or INFU?
InfuSystem Holdings, Inc.
(INFU) is the more profitable company, earning 4. 6% net margin versus -9. 5% for Forian Inc. — meaning it keeps 4. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INFU leads at 8. 3% versus -8. 2% for FORA. At the gross margin level — before operating expenses — CSGP leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FORA or CSGP or Z or INFU more undervalued right now?
On forward earnings alone, Zillow Group, Inc.
Class C (Z) trades at 14. 1x forward P/E versus 22. 2x for InfuSystem Holdings, Inc. — 8. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for Z: 111. 0% to $67. 75.
08Which pays a better dividend — FORA or CSGP or Z or INFU?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is FORA or CSGP or Z or INFU better for a retirement portfolio?
For long-horizon retirement investors, Forian Inc.
(FORA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21)). Both have compounded well over 10 years (FORA: -90. 5%, Z: -7. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FORA and CSGP and Z and INFU?
These companies operate in different sectors (FORA (Healthcare) and CSGP (Real Estate) and Z (Communication Services) and INFU (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FORA is a small-cap high-growth stock; CSGP is a mid-cap high-growth stock; Z is a small-cap high-growth stock; INFU is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.